Posturography-Neuropathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

67 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-19

Study Completion Date

2024-01-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

If the classification between hereditary and acquired neuropathy is often easy, there is no completely specific marker allowing the distinction between the two etiologies. Clinical experience suggests that hereditary neuropathies have less impact on balance and gait than the acquired neuropathies at equivalent level of impairment, but this has never been clearly demonstrated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Core Stability Exercises and Hereditary Ataxia

NCT04750850

Hereditary Ataxia Spinocerebellar Degenerations Cerebellar Ataxia

COMPLETED NA

Walking Strategies in Usual Locomotion of Lower Limb Amputees

NCT05420623

Lower Limb Amputation

COMPLETED

Gait Disorders in Patients With Cognitive Decline

NCT03399591

Gait Disorders, Neurologic

UNKNOWN

From Movement Preparation to Gait Execution in ALS

NCT01874808

Amyotrophic Lateral Sclerosis

COMPLETED

Proprioception on Balance and Gait in Hemiparetics

NCT05027841

Hemiparesis Proprioceptive Disorders Gait, Hemiplegic

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuropathy Demyelinating

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

demyelinating hereditary neuropathy

adult patients with demyelinating hereditary neuropathy type CMT 1A.

Group Type EXPERIMENTAL

Motion analysis

Intervention Type OTHER

Gait and posture recording

demyelinating inflammatory neuropathy

adult patients with acquired demyelinating inflammatory neuropathy.

Group Type EXPERIMENTAL

Motion analysis

Intervention Type OTHER

Gait and posture recording

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motion analysis

Gait and posture recording

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* CMT1A for molecular-proven Group 1 (PMP22 duplication)
* IPDC likely or defined for Group 2
* Able to walk 10 m unassisted

Exclusion Criteria

* Neurological history other than neuropathy: epilepsy, stroke, dementia
* Pregnant women
* Person under guardianship or trusteeship
* Musculoskeletal conditions other than neuropathy impairing walking abilities
* Major comorbidity considered a contraindication by the investigator (cancer, unstable angor, etc.)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No